Evidence map›Paper›PMID 28593137›Full record

ArticleFEBS open bio2017

MSK1 regulates transcriptional induction of Arc/Arg3.1 in response to neurotrophins.

Chris J Hunter, Judit Remenyi, Sonia A Correa, Lucia Privitera, Kathleen M S E Reyskens, Kirsty J Martin, Rachel Toth, Bruno G Frenguelli, J Simon C Arthur

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Experience Recruits MSK1 to Expand the Dynamic Range of Synapses and Enhance Cognition.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Chris J HunterMRC Protein Phosphorylation Unit College of Life Sciences Sir James Black Centre University of Dundee UK.
Judit RemenyiWellcome Trust Centre for Gene Regulation and Expression Wellcome Trust Building College of Life Sciences University of Dundee UK.
Sonia A CorreaBradford School of Pharmacy Faculty of Life Sciences University of Bradford UK.
Lucia PriviteraSchool of Life Sciences University of Warwick Coventry UK.
Kathleen M S E ReyskensDivision of Cell Signalling and Immunology Wellcome Trust Building College of Life Sciences University of Dundee UK.
Kirsty J MartinMRC Protein Phosphorylation Unit College of Life Sciences Sir James Black Centre University of Dundee UK.
Rachel TothMRC Protein Phosphorylation Unit College of Life Sciences Sir James Black Centre University of Dundee UK.
Bruno G FrenguelliSchool of Life Sciences University of Warwick Coventry UK.
J Simon C ArthurDivision of Cell Signalling and Immunology Wellcome Trust Building College of Life Sciences University of Dundee UK.
University of Dundee · GBUniversity of Warwick · GBMRC Protein Phosphorylation and Ubiquitylation Unit · GBUniversity of Bradford · GBWellcome Trust Centre for the History of Medicine · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The immediate early gene activity-regulated cytoskeletal protein (Arc)/Arg3.1 and the neurotrophin brain-derived neurotrophic factor (BDNF) play important roles in synaptic plasticity and learning and memory in the mammalian brain. However, the mechanisms by which BDNF regulates the expression of Arc/Arg3.1 are unclear. In this study, we show that BDNF acts via the ERK1/2 pathway to activate the nuclear kinase mitogen- and stress-activated protein kinase 1 (MSK1). MSK1 then induces Arc/Arg3.1 expression via the phosphorylation of histone H3 at the Arc/Arg3.1 promoter. MSK1 can also phosphorylate the transcription factor cyclic-AMP response element-binding protein (CREB) on Ser133. However, this is not required for BDNF-induced Arc.Arg3.1 transcription as a Ser133Ala knockin mutation had no effect on Arc/Arg3.1 induction. In parallel, ERK1/2 directly activates Arc/Arg3.1 mRNA transcription via at least one serum response element on the promoter, which bind a complex of the Serum Response Factor (SRF) and a Ternary Complex Factor (TCF).

Indexed as

Arc/Arg3.1BDNFCREBglutamatehistone H3MSK1neurotrophinsNMDA

Identifiers

PMID28593137
PMCPMC5458472
OpenAlexW2607004916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.